在心房动中坚持口服血栓预防:临床医生的概述
Tatjana Potpara1,2, Bogdan G Markovic1, Marek Grygier3
1Medical Faculty, University of Belgrade, Dr Subotica starijeg 8, Belgrade 11000, Serbia.
概括
口服抗凝剂治疗 (OAC) 对于预防心房动 (AF) 中的中风至关重要. 患者对OAC的不良坚持是一个重大问题,导致不良结果和成本增加.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 口服抗凝药疗法 (OAC) 对于心房动 (AF) 患者中风预防至关重要.
- 患者的坚持和持久性在现实临床环境中显著影响OAC的有效性.
- 低于最佳的OAC坚持是普遍的,患者经常错过剂量,显著的百分比拒绝治疗.
研究的目的:
- 对AF的OAC治疗中药物坚持的概念进行审查.
- 探索OAC不遵守的决定因素,流行率和临床意义.
- 讨论改善OAC遵守的策略和替代性血栓预防的选择.
主要方法:
- 文献综述和现有证据的综合对AF的OAC遵守的现有证据.
- 分析影响患者对OAC的坚持和持续性的因素.
- 检查与OAC不遵守相关的临床结果和经济成本.
主要成果:
- 有证据表明,患者大约每四天错过一次OAC剂量.
- 15%的高风险AF患者有资格接受OAC拒绝治疗.
- 不良的坚持与中风,住院,死亡率和出血的风险增加有关.
结论:
- 改善OAC坚持对于有效预防AF中风至关重要.
- 了解坚持的决定因素是制定有针对性的干预措施的关键.
- 对于非粘附性AF患者,需要使用替代性血栓预防策略.
相关概念视频
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Venous Thrombosis IV: Nursing Management
196
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
196
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
320
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
320


